Korean J Thorac Cardiovasc Surg.
2020 Aug;53(4):168-171. 10.5090/kjtcs.2020.53.4.168.
Adjuvant Therapy for Esophageal Squamous Cell Carcinoma
- Affiliations
-
- 1Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- KMID: 2505159
- DOI: http://doi.org/10.5090/kjtcs.2020.53.4.168
Abstract
- Adjuvant therapy for completely resected esophageal squamous cell carcinoma is lesscommonly applied in clinical practice than neoadjuvant therapy, but it plays a substantialrole in improving survival for esophageal cancer patients. This article presents a concise reviewof the evidence regarding adjuvant therapy for esophageal squamous cell carcinomaand future directions, particularly immunotherapy.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Cutaneous Metastasis of Esophageal Squamous Cell Carcinoma Mimicking Benign Soft Tissue Tumor
- The Current Evidence on Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma
- Diagnosis and Clinical Management of Esophageal Squamous Dysplasia
- Immunotherapy for Advanced/Metastatic Esophageal Squamous Cell Carcinoma
- What Is the Next Step after Endoscopic Resection of Superficial Esophageal Squamous Cell Carcinoma?
